Drug intelligence / Profile preview

Jiedu Tongluo Shengjin

Development stage
Phase 1
Lead developer
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Administration
Oral
01

Overview

Jiedu Tongluo Shengjin is a Traditional Chinese Medicine (TCM) herbal formulation developed as an in-hospital preparation by the Yueyang Integrated Traditional Chinese and Western Medicine Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine. It is primarily indicated for the treatment of Sjögren's syndrome, an autoimmune disorder characterized by the destruction of exocrine glands leading to severe dryness of the eyes and mouth. The formula's name reflects its core therapeutic principles in TCM: clearing heat and detoxifying (Jiedu), unblocking the collaterals (Tongluo), and promoting the production of body fluids (Shengjin). Key botanical components include Peony (Shaoyao) and Glycyrrhizae (Gancao), which are studied in various compatibility ratios to optimize clinical efficacy and immunomodulatory effects. The drug is typically administered in a granule dosage form.

Brand names
jiedu tongluo shengjin decoction
Other names
Jiedu Tongluo Shengjin GranulesJiedu Tongluo Shengjin formula

Beyond the preview

Go deeper on Jiedu Tongluo Shengjin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiedu Tongluo Shengjin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call